BIO: Bio-Rad Laboratories, Inc. Stock

by  •  • Comments Off on BIO: Bio-Rad Laboratories, Inc. Stock

SIC 3826 – Laboratory Analytical Instruments

Valuation
Market Cap ($M) 5,024.78
Enterprise Value ($M) 5,695.78
Book Value ($M) 6,679.40
Book Value / Share 301.66
Price / Book 0.75
NCAV ($M) 189.10
NCAV / Share 6.84
Price / NCAV 26.57

Profitability (mra)
Return on Invested Capital (ROIC) -0.27
Return on Assets (ROA) -0.17
Return on Equity (ROE) -0.24

Liquidity (mrq)
Quick Ratio 4.43
Current Ratio 5.99

Balance Sheet (mrq) ($M)
Current Assets 3,036.60
Assets 9,526.90
Liabilities 2,847.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,566.50
Operating Income 310.00
Net Income -1,844.20
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 455.20
Cash from Investing -160.20
Cash from Financing -218.80

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-05 13G First Eagle Investment Management, LLC 6.80
12-20 13G/A Vanguard Group Inc 8.37 900.00
11-14 13G Van Eck Associates Corp 5.73
11-08 13G/A BlackRock, Inc. 8.50 0.00
10-10 13G Bank Of Nova Scotia 6.50

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT P
2025-02-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PUR
2024-10-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 68,166 281,161 24.24
2025-05-29 48,386 189,518 25.53
2025-05-28 50,231 229,596 21.88
2025-05-27 62,734 242,524 25.87

(click for more detail)

Similar Companies
A – Agilent Technologies, Inc. AME – AMETEK, Inc.
AVTR – Avantor, Inc. BIO.B – Bio-Rad Laboratories, Inc.
BMI – Badger Meter, Inc.


Financial data and stock pages provided by
Fintel.io